IBD is characterized by activation of T cell-derived pro-inflammatory cytokines, such as IL-17 [8], TNFα [9], and IFN-γ [10,11], as well as malfunction of peripheral- and tissue-specific regulatory T cells [12,13]. The gene discussed is IL17A; the disease is inflammatory bowel disease.